Biopharmaceuticals
Immunomedics is advancing the science of antibody-drug conjugate (ADC) technology with its next-generation ADC linker, designed to effectively balance directed delivery of an active therapeutic agent to the tumor site with manageable side effects to help transform the lives of people with hard-to-treat cancers.
Usama Malik
Loretta Itri, M.D., F.A.C.P.,
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.